White, Lucy. "Mylan Lab's Proposed Merger with King Pharmaceuticals—courseware." Harvard Business School Spreadsheet Supplement 214-709, May 2014. (Revised June 2016.) ...

Pfizer and Mylan Pharmaceutical’s have signed a definitive agreement to establish an exclusive long-term collaboration, to develop, manufacture, distribute and market generic drugs in Japan.

In June, Kleeh granted a permanent injunction that blocked drugmakers including, Mylan Pharmaceuticals/Biocon Biologics from launchign generic Eylea. The same judge in June also issued a ...

Mylan has launched its generic version of ... The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns ...

Mylan President Rajiv Malik and Emcure Pharmaceuticals CEO Satish Mehta are both named as defendants to the 243-page complaint, which was transferred from Connecticut to Philadelphia. Led by ...

Pfizer (PFL) announced it is spinning off its off-patent drug business and combining it with Real Money Stock of the Day Mylan (MYL) to create a new company. Cramer says that he's keeping an eye ...

U.S. pharmaceutical giant Viatris Inc has been fined 7.58 million dirhams ($760,000) by Morocco's competition regulator for ...

American pharmaceutical company Viatris has been fined 7.58 million dirhams by the Moroccan Competition Council for failing ...

Company Information Key Financials Profit As A % Of Earnings Per Share Total Return To Investors © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this ...